Global Oncology Clinical Trial Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 102
Published Date: 09 Jan 2022
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Oncology Clinical Trial market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncology Clinical Trial market size is estimated to be worth US$ 14050 million in 2021 and is forecast to a readjusted size of USD 17110 million by 2028 with a CAGR of 2.9% during review period. Hospital accounting for % of the Oncology Clinical Trial global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prostate Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Oncology Clinical Trial include IQVIA, Charles River Laboratory, ICON Plc, Medelis, Inc., and Medpace Holdings, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology Clinical Trial market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prostate Cancer
Lung Cancer
Breast Cancer
Leukemia
Others
Market segment by Application, can be divided into
Hospital
Clinic
Lab
Market segment by players, this report covers
IQVIA
Charles River Laboratory
ICON Plc
Medelis, Inc.
Medpace Holdings, Inc.
PAREXEL International
Pharmaceutical Product Development, LLC
Pivotal
PRA Health Sciences
Syneos Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oncology Clinical Trial product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oncology Clinical Trial, with revenue, gross margin and global market share of Oncology Clinical Trial from 2019 to 2022.
Chapter 3, the Oncology Clinical Trial competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oncology Clinical Trial market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Oncology Clinical Trial research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oncology Clinical Trial
1.2 Classification of Oncology Clinical Trial by Type
1.2.1 Overview: Global Oncology Clinical Trial Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Oncology Clinical Trial Revenue Market Share by Type in 2021
1.2.3 Prostate Cancer
1.2.4 Lung Cancer
1.2.5 Breast Cancer
1.2.6 Leukemia
1.2.7 Others
1.3 Global Oncology Clinical Trial Market by Application
1.3.1 Overview: Global Oncology Clinical Trial Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Global Oncology Clinical Trial Market Size & Forecast
1.5 Global Oncology Clinical Trial Market Size and Forecast by Region
1.5.1 Global Oncology Clinical Trial Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Oncology Clinical Trial Market Size by Region, (2017-2022)
1.5.3 North America Oncology Clinical Trial Market Size and Prospect (2017-2028)
1.5.4 Europe Oncology Clinical Trial Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Oncology Clinical Trial Market Size and Prospect (2017-2028)
1.5.6 South America Oncology Clinical Trial Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Oncology Clinical Trial Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Clinical Trial Market Drivers
1.6.2 Oncology Clinical Trial Market Restraints
1.6.3 Oncology Clinical Trial Trends Analysis
2.1 IQVIA
2.1.1 IQVIA Details
2.1.2 IQVIA Major Business
2.1.3 IQVIA Oncology Clinical Trial Product and Solutions
2.1.4 IQVIA Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 IQVIA Recent Developments and Future Plans
2.2 Charles River Laboratory
2.2.1 Charles River Laboratory Details
2.2.2 Charles River Laboratory Major Business
2.2.3 Charles River Laboratory Oncology Clinical Trial Product and Solutions
2.2.4 Charles River Laboratory Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Charles River Laboratory Recent Developments and Future Plans
2.3 ICON Plc
2.3.1 ICON Plc Details
2.3.2 ICON Plc Major Business
2.3.3 ICON Plc Oncology Clinical Trial Product and Solutions
2.3.4 ICON Plc Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 ICON Plc Recent Developments and Future Plans
2.4 Medelis, Inc.
2.4.1 Medelis, Inc. Details
2.4.2 Medelis, Inc. Major Business
2.4.3 Medelis, Inc. Oncology Clinical Trial Product and Solutions
2.4.4 Medelis, Inc. Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Medelis, Inc. Recent Developments and Future Plans
2.5 Medpace Holdings, Inc.
2.5.1 Medpace Holdings, Inc. Details
2.5.2 Medpace Holdings, Inc. Major Business
2.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Product and Solutions
2.5.4 Medpace Holdings, Inc. Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Medpace Holdings, Inc. Recent Developments and Future Plans
2.6 PAREXEL International
2.6.1 PAREXEL International Details
2.6.2 PAREXEL International Major Business
2.6.3 PAREXEL International Oncology Clinical Trial Product and Solutions
2.6.4 PAREXEL International Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 PAREXEL International Recent Developments and Future Plans
2.7 Pharmaceutical Product Development, LLC
2.7.1 Pharmaceutical Product Development, LLC Details
2.7.2 Pharmaceutical Product Development, LLC Major Business
2.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Product and Solutions
2.7.4 Pharmaceutical Product Development, LLC Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pharmaceutical Product Development, LLC Recent Developments and Future Plans
2.8 Pivotal
2.8.1 Pivotal Details
2.8.2 Pivotal Major Business
2.8.3 Pivotal Oncology Clinical Trial Product and Solutions
2.8.4 Pivotal Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pivotal Recent Developments and Future Plans
2.9 PRA Health Sciences
2.9.1 PRA Health Sciences Details
2.9.2 PRA Health Sciences Major Business
2.9.3 PRA Health Sciences Oncology Clinical Trial Product and Solutions
2.9.4 PRA Health Sciences Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 PRA Health Sciences Recent Developments and Future Plans
2.10 Syneos Health
2.10.1 Syneos Health Details
2.10.2 Syneos Health Major Business
2.10.3 Syneos Health Oncology Clinical Trial Product and Solutions
2.10.4 Syneos Health Oncology Clinical Trial Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Syneos Health Recent Developments and Future Plans
3.1 Global Oncology Clinical Trial Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Clinical Trial Players Market Share in 2021
3.2.2 Top 10 Oncology Clinical Trial Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Oncology Clinical Trial Players Head Office, Products and Services Provided
3.4 Oncology Clinical Trial Mergers & Acquisitions
3.5 Oncology Clinical Trial New Entrants and Expansion Plans
4.1 Global Oncology Clinical Trial Revenue and Market Share by Type (2017-2022)
4.2 Global Oncology Clinical Trial Market Forecast by Type (2023-2028)
5.1 Global Oncology Clinical Trial Revenue Market Share by Application (2017-2022)
5.2 Global Oncology Clinical Trial Market Forecast by Application (2023-2028)
6.1 North America Oncology Clinical Trial Revenue by Type (2017-2028)
6.2 North America Oncology Clinical Trial Revenue by Application (2017-2028)
6.3 North America Oncology Clinical Trial Market Size by Country
6.3.1 North America Oncology Clinical Trial Revenue by Country (2017-2028)
6.3.2 United States Oncology Clinical Trial Market Size and Forecast (2017-2028)
6.3.3 Canada Oncology Clinical Trial Market Size and Forecast (2017-2028)
6.3.4 Mexico Oncology Clinical Trial Market Size and Forecast (2017-2028)
7.1 Europe Oncology Clinical Trial Revenue by Type (2017-2028)
7.2 Europe Oncology Clinical Trial Revenue by Application (2017-2028)
7.3 Europe Oncology Clinical Trial Market Size by Country
7.3.1 Europe Oncology Clinical Trial Revenue by Country (2017-2028)
7.3.2 Germany Oncology Clinical Trial Market Size and Forecast (2017-2028)
7.3.3 France Oncology Clinical Trial Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Oncology Clinical Trial Market Size and Forecast (2017-2028)
7.3.5 Russia Oncology Clinical Trial Market Size and Forecast (2017-2028)
7.3.6 Italy Oncology Clinical Trial Market Size and Forecast (2017-2028)
8.1 Asia-Pacific Oncology Clinical Trial Revenue by Type (2017-2028)
8.2 Asia-Pacific Oncology Clinical Trial Revenue by Application (2017-2028)
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Region
8.3.1 Asia-Pacific Oncology Clinical Trial Revenue by Region (2017-2028)
8.3.2 China Oncology Clinical Trial Market Size and Forecast (2017-2028)
8.3.3 Japan Oncology Clinical Trial Market Size and Forecast (2017-2028)
8.3.4 South Korea Oncology Clinical Trial Market Size and Forecast (2017-2028)
8.3.5 India Oncology Clinical Trial Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Oncology Clinical Trial Market Size and Forecast (2017-2028)
8.3.7 Australia Oncology Clinical Trial Market Size and Forecast (2017-2028)
9.1 South America Oncology Clinical Trial Revenue by Type (2017-2028)
9.2 South America Oncology Clinical Trial Revenue by Application (2017-2028)
9.3 South America Oncology Clinical Trial Market Size by Country
9.3.1 South America Oncology Clinical Trial Revenue by Country (2017-2028)
9.3.2 Brazil Oncology Clinical Trial Market Size and Forecast (2017-2028)
9.3.3 Argentina Oncology Clinical Trial Market Size and Forecast (2017-2028)
10.1 Middle East & Africa Oncology Clinical Trial Revenue by Type (2017-2028)
10.2 Middle East & Africa Oncology Clinical Trial Revenue by Application (2017-2028)
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Country
10.3.1 Middle East & Africa Oncology Clinical Trial Revenue by Country (2017-2028)
10.3.2 Turkey Oncology Clinical Trial Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Oncology Clinical Trial Market Size and Forecast (2017-2028)
10.3.4 UAE Oncology Clinical Trial Market Size and Forecast (2017-2028)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oncology Clinical Trial Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Oncology Clinical Trial Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Oncology Clinical Trial Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Oncology Clinical Trial Revenue (USD Million) by Region (2017-2022)
Table 5. Global Oncology Clinical Trial Revenue Market Share by Region (2023-2028)
Table 6. IQVIA Corporate Information, Head Office, and Major Competitors
Table 7. IQVIA Major Business
Table 8. IQVIA Oncology Clinical Trial Product and Solutions
Table 9. IQVIA Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Charles River Laboratory Corporate Information, Head Office, and Major Competitors
Table 11. Charles River Laboratory Major Business
Table 12. Charles River Laboratory Oncology Clinical Trial Product and Solutions
Table 13. Charles River Laboratory Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. ICON Plc Corporate Information, Head Office, and Major Competitors
Table 15. ICON Plc Major Business
Table 16. ICON Plc Oncology Clinical Trial Product and Solutions
Table 17. ICON Plc Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Medelis, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Medelis, Inc. Major Business
Table 20. Medelis, Inc. Oncology Clinical Trial Product and Solutions
Table 21. Medelis, Inc. Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Medpace Holdings, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Medpace Holdings, Inc. Major Business
Table 24. Medpace Holdings, Inc. Oncology Clinical Trial Product and Solutions
Table 25. Medpace Holdings, Inc. Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. PAREXEL International Corporate Information, Head Office, and Major Competitors
Table 27. PAREXEL International Major Business
Table 28. PAREXEL International Oncology Clinical Trial Product and Solutions
Table 29. PAREXEL International Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Pharmaceutical Product Development, LLC Corporate Information, Head Office, and Major Competitors
Table 31. Pharmaceutical Product Development, LLC Major Business
Table 32. Pharmaceutical Product Development, LLC Oncology Clinical Trial Product and Solutions
Table 33. Pharmaceutical Product Development, LLC Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pivotal Corporate Information, Head Office, and Major Competitors
Table 35. Pivotal Major Business
Table 36. Pivotal Oncology Clinical Trial Product and Solutions
Table 37. Pivotal Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. PRA Health Sciences Corporate Information, Head Office, and Major Competitors
Table 39. PRA Health Sciences Major Business
Table 40. PRA Health Sciences Oncology Clinical Trial Product and Solutions
Table 41. PRA Health Sciences Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Syneos Health Corporate Information, Head Office, and Major Competitors
Table 43. Syneos Health Major Business
Table 44. Syneos Health Oncology Clinical Trial Product and Solutions
Table 45. Syneos Health Oncology Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Oncology Clinical Trial Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Oncology Clinical Trial Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Oncology Clinical Trial by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Oncology Clinical Trial Players Head Office, Products and Services Provided
Table 50. Oncology Clinical Trial Mergers & Acquisitions in the Past Five Years
Table 51. Oncology Clinical Trial New Entrants and Expansion Plans
Table 52. Global Oncology Clinical Trial Revenue (USD Million) by Type (2017-2022)
Table 53. Global Oncology Clinical Trial Revenue Share by Type (2017-2022)
Table 54. Global Oncology Clinical Trial Revenue Forecast by Type (2023-2028)
Table 55. Global Oncology Clinical Trial Revenue by Application (2017-2022)
Table 56. Global Oncology Clinical Trial Revenue Forecast by Application (2023-2028)
Table 57. North America Oncology Clinical Trial Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Oncology Clinical Trial Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Oncology Clinical Trial Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Oncology Clinical Trial Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Oncology Clinical Trial Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Oncology Clinical Trial Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Oncology Clinical Trial Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Oncology Clinical Trial Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Oncology Clinical Trial Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Oncology Clinical Trial Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Oncology Clinical Trial Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Oncology Clinical Trial Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Oncology Clinical Trial Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Oncology Clinical Trial Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Oncology Clinical Trial Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Oncology Clinical Trial Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Oncology Clinical Trial Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Oncology Clinical Trial Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Oncology Clinical Trial Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Oncology Clinical Trial Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Oncology Clinical Trial Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Oncology Clinical Trial Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Oncology Clinical Trial Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Oncology Clinical Trial Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Oncology Clinical Trial Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Oncology Clinical Trial Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Oncology Clinical Trial Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Oncology Clinical Trial Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Oncology Clinical Trial Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Oncology Clinical Trial Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Oncology Clinical Trial Picture
Figure 2. Global Oncology Clinical Trial Revenue Market Share by Type in 2021
Figure 3. Prostate Cancer
Figure 4. Lung Cancer
Figure 5. Breast Cancer
Figure 6. Leukemia
Figure 7. Others
Figure 8. Oncology Clinical Trial Revenue Market Share by Application in 2021
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Lab Picture
Figure 12. Global Oncology Clinical Trial Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Oncology Clinical Trial Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Oncology Clinical Trial Revenue Market Share by Region (2017-2028)
Figure 15. Global Oncology Clinical Trial Revenue Market Share by Region in 2021
Figure 16. North America Oncology Clinical Trial Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Oncology Clinical Trial Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Oncology Clinical Trial Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Oncology Clinical Trial Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Oncology Clinical Trial Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Oncology Clinical Trial Market Drivers
Figure 22. Oncology Clinical Trial Market Restraints
Figure 23. Oncology Clinical Trial Market Trends
Figure 24. IQVIA Recent Developments and Future Plans
Figure 25. Charles River Laboratory Recent Developments and Future Plans
Figure 26. ICON Plc Recent Developments and Future Plans
Figure 27. Medelis, Inc. Recent Developments and Future Plans
Figure 28. Medpace Holdings, Inc. Recent Developments and Future Plans
Figure 29. PAREXEL International Recent Developments and Future Plans
Figure 30. Pharmaceutical Product Development, LLC Recent Developments and Future Plans
Figure 31. Pivotal Recent Developments and Future Plans
Figure 32. PRA Health Sciences Recent Developments and Future Plans
Figure 33. Syneos Health Recent Developments and Future Plans
Figure 34. Global Oncology Clinical Trial Revenue Share by Players in 2021
Figure 35. Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Oncology Clinical Trial Revenue Market Share in 2021
Figure 37. Global Top 10 Players Oncology Clinical Trial Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Oncology Clinical Trial Revenue Share by Type in 2021
Figure 40. Global Oncology Clinical Trial Market Share Forecast by Type (2023-2028)
Figure 41. Global Oncology Clinical Trial Revenue Share by Application in 2021
Figure 42. Global Oncology Clinical Trial Market Share Forecast by Application (2023-2028)
Figure 43. North America Oncology Clinical Trial Sales Market Share by Type (2017-2028)
Figure 44. North America Oncology Clinical Trial Sales Market Share by Application (2017-2028)
Figure 45. North America Oncology Clinical Trial Revenue Market Share by Country (2017-2028)
Figure 46. United States Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Oncology Clinical Trial Sales Market Share by Type (2017-2028)
Figure 50. Europe Oncology Clinical Trial Sales Market Share by Application (2017-2028)
Figure 51. Europe Oncology Clinical Trial Revenue Market Share by Country (2017-2028)
Figure 52. Germany Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Oncology Clinical Trial Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Oncology Clinical Trial Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Oncology Clinical Trial Revenue Market Share by Region (2017-2028)
Figure 60. China Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Oncology Clinical Trial Sales Market Share by Type (2017-2028)
Figure 67. South America Oncology Clinical Trial Sales Market Share by Application (2017-2028)
Figure 68. South America Oncology Clinical Trial Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Oncology Clinical Trial Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Oncology Clinical Trial Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Oncology Clinical Trial Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Oncology Clinical Trial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
IQVIA Charles River Laboratory ICON Plc Medelis, Inc. Medpace Holdings, Inc. PAREXEL International Pharmaceutical Product Development, LLC Pivotal PRA Health Sciences Syneos Health
Related Reports
29 Jan 2021
Medical Care
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
